Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.63EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.63EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.263EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.263EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.263ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.263ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.263EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.263EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.263ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.263ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.135EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.135EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.135ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.135ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.135EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.135EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.135ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.135ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.35ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.35ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.35ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
A.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
A.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
A.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used